The present invention relates to a pharmaceutical composition and a functional health food composition for preventing or treating obesity or fatty liver containing an arginase inhibitor. The composition containing the arginase inhibitor according to the present invention is useful in the prevention and treatment of obesity or fatty liver, as the composition has an effect in reducing body weight increase, body fat content and hepatic triglyceride content.La présente invention concerne une composition pharmaceutique et une composition daliment naturel fonctionnel pour prévenir ou traiter lobésité ou la stéatose hépatique contenant un inhibiteur darginase. La composition contenant linhibiteur darginase selon la présente invention est utile pour prévenir et traiter lobésité ou la stéatose hépatique, puisque la composition est efficace pour réduire laugmentation du poids corporel, ladiposité et la teneur en triglycérides hépatiques.본 발명은 아르기나아제 억제제를 함유하는 비만 또는 지방간의 예방 또는 치료용 약학 조성물 및 건강기능식품 조성물에 관한 것으로, 본 발명에 따른 아르기나아제 억제제를 함유한 조성물은 체중증가량, 체지방량 및 간 내 중성지방량 감소 효과가 있어 비만 또는 지방간의 예방 및 치료에 유용하다.
